These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 9702065)

  • 1. [Disorders caused by mutations of the thyrotropin receptor].
    Kosugi S
    Nihon Rinsho; 1998 Jul; 56(7):1856-60. PubMed ID: 9702065
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thyrotropin receptor mutations as a tool to understand thyrotropin receptor action.
    Wonerow P; Neumann S; Gudermann T; Paschke R
    J Mol Med (Berl); 2001 Dec; 79(12):707-21. PubMed ID: 11862314
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the mouse TSH receptor equivalent to human constitutively activating TSH receptor mutations also cause constitutive activity.
    Neumann S; Krohn K; Chey S; Paschke R
    Horm Metab Res; 2001 May; 33(5):263-9. PubMed ID: 11440271
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Non-autoimmune hyperthyroidism and hyperfunctioning thyroid adenomas caused by activating mutation of the thyrotropin receptor].
    Kosugi S
    Nihon Rinsho; 2002 Feb; 60(2):291-6. PubMed ID: 11857916
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Premature birth and low birth weight associated with nonautoimmune hyperthyroidism due to an activating thyrotropin receptor gene mutation.
    Vaidya B; Campbell V; Tripp JH; Spyer G; Hattersley AT; Ellard S
    Clin Endocrinol (Oxf); 2004 Jun; 60(6):711-8. PubMed ID: 15163335
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Late manifestation of subclinical hyperthyroidism after goitrogenesis in an index patient with a N670S TSH receptor germline mutation masquerading as TSH receptor antibody negative Graves' disease.
    Schaarschmidt J; Paschke S; Özerden M; Jäschke H; Huth S; Eszlinger M; Meller J; Paschke R
    Horm Metab Res; 2012 Dec; 44(13):962-5. PubMed ID: 22763653
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and evaluation of constitutively active thyroid stimulating hormone receptor mutations.
    Lado-Abeal J; Quisenberry LR; Castro-Piedras I
    Methods Enzymol; 2010; 484():375-95. PubMed ID: 21036242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [From gene to disease; thyroid stimulating hormone receptor, hyperthyroidism and hypothyroidism].
    Wiersinga WM
    Ned Tijdschr Geneeskd; 2001 May; 145(18):869-71. PubMed ID: 11379397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thyrotropin receptor-associated diseases: from adenomata to Graves disease.
    Davies TF; Ando T; Lin RY; Tomer Y; Latif R
    J Clin Invest; 2005 Aug; 115(8):1972-83. PubMed ID: 16075037
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The gene for the thyrotropin receptor (TSHR) as a candidate gene for congenital hypothyroidism with thyroid dysgenesis.
    Krude H; Biebermann H; Göpel W; Grüters A
    Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():117-20. PubMed ID: 8981017
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Constitutively activating TSH receptor mutations as the cause of toxic thyroid adenoma, multinodular toxic goiter and autosomal dominant non autoimmune hyperthyroidism.
    Paschke R
    Exp Clin Endocrinol Diabetes; 1996; 104 Suppl 4():129-32. PubMed ID: 8981020
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetics and phenomics of inherited and sporadic non-autoimmune hyperthyroidism.
    Gozu HI; Lublinghoff J; Bircan R; Paschke R
    Mol Cell Endocrinol; 2010 Jun; 322(1-2):125-34. PubMed ID: 20138963
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathology of the TSH receptor.
    Duprez L; Parma J; Van Sande J; Rodien P; Sabine C; Abramowicz M; Dumont JE; Vassart G
    J Pediatr Endocrinol Metab; 1999 Apr; 12 Suppl 1():295-302. PubMed ID: 10698593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pathologic manifestations of hormonal receptor mutations].
    Milgrom E
    Bull Acad Natl Med; 2000; 184(3):605-16; discussion 617-9. PubMed ID: 10989556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Constitutively activating mutations of the thyrotropin receptor and thyroid disease.
    Führer D; Holzapfel HP; Wonerow P; Paschke R
    Eur J Med Res; 1996 Jul; 1(10):460-4. PubMed ID: 9438142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subclinical hyperthyroidism due to a thyrotropin receptor (TSHR) gene mutation (S505R).
    Pohlenz J; Pfarr N; Krüger S; Hesse V
    Acta Paediatr; 2006 Dec; 95(12):1685-7. PubMed ID: 17129985
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Somatic mutations causing constitutive activity of the thyrotropin receptor are the major cause of hyperfunctioning thyroid adenomas: identification of additional mutations activating both the cyclic adenosine 3',5'-monophosphate and inositol phosphate-Ca2+ cascades.
    Parma J; Van Sande J; Swillens S; Tonacchera M; Dumont J; Vassart G
    Mol Endocrinol; 1995 Jun; 9(6):725-33. PubMed ID: 8592518
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Shared sporadic and somatic thyrotropin receptor mutations display more active in vitro activities than familial thyrotropin receptor mutations.
    Lueblinghoff J; Eszlinger M; Jaeschke H; Mueller S; Bircan R; Gozu H; Sancak S; Akalin S; Paschke R
    Thyroid; 2011 Mar; 21(3):221-9. PubMed ID: 21190443
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The detection of somatic mutations of thyrotropin receptor gene in fine needle biopsy samples from thyroid nodules.
    Syrenicz A; Kurzawski G; Ciechanowicz A
    Endocr Regul; 1999 Sep; 33(3):95-101. PubMed ID: 10571960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [TSH receptor double mutation in functional autonomic thyroid nodule].
    Semlitsch G; Höfler G; Langsteger W; Lax S; Zatloukal K; Berger A; Eber O
    Acta Med Austriaca; 1995; 22(4):75-7. PubMed ID: 8835426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.